ANTERIS

WIPO WIPO 2020

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark ANTERIS was filed as Word mark on 05/14/2020 at the World Intellectual Property Organization.

Trademark Details Last update: November 2, 2022

Trademark form Word mark
File reference 1539817
Countries Brazil Canada Switzerland China United Kingdom Israel India Japan Mexico Norway New Zealand Russia Singapore
Base trademark US No. , November 8, 2024
Application date May 14, 2020
Expiration date May 14, 2030

Trademark owner

Toowong Tower, Level 3,
9 Sherwood Rd
AU

Trademark representatives

60 South Sixth Street, Suite 2700 Minneapolis MN 55402 US

goods and services

05 Engineered biological tissue for use in cardiovascular repair, soft tissue repair, hernia repair, regenerative medicine and other medical purposes; biological tissue grafts; implants comprising living tissue; surgical implants comprising living tissue; biological tissue grafts, implantable scaffolds, and tissue cultures for medical and veterinary purposes; medical preparations for the regeneration of tissue; surgical, medical, and veterinary products and preparations, namely, preparations used for use in cardiovascular surgery and for treating cardio and vascular defects; sanitary preparations for medical purposes; natural biomaterials for augmentation of tissue for medical purposes; prepared collagenous biological tissue intended for subsequent grafting, transplantation and tissue support; medical preparations for the treatment, reconstruction, re-contouring and repair of tissue and cardiac structure
10 Surgical implants comprising artificial material; surgical implants comprising artificial material and associated surgical instrument sets; surgical instruments and apparatus; medical apparatus and instruments for treating cardiovascular disease; medical products, namely, cardiovascular devices in the nature of heart valves, valve leaflets, catheters, stents, and other medical apparatus and instruments for the treatment of cardiovascular disease; medical devices, namely, artificial heart valves and heart valve delivery catheters; bioprosthetic heart valves; transcatheter delivery systems for prosthetic heart valves and leaflets for cardiovascular repair; catheter delivery systems for prosthetic heart valves and leaflets for cardiovascular repair
40 Tissue treatment process services; tissue processing services, namely, anti-calcification treatment of biological tissue intended for subsequent implantation; custom manufacturing of medical devices for others

Trademark history

Date Document number Area Entry
October 19, 2022 2022/44 Gaz CA RAW: Rule 18ter(2)(ii) GP following a provisional refusal
April 5, 2022 2022/14 Gaz NO RAW: Rule 18ter(2)(ii) GP following a provisional refusal
January 27, 2022 2022/5 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
December 13, 2021 2022/1 Gaz MX Rejection
December 10, 2021 2021/49 Gaz GB Rejection
October 26, 2021 2021/44 Gaz CA Rejection
July 29, 2021 2021/32 Gaz JP Rejection
July 9, 2021 2021/30 Gaz CH RAW: Rule 18ter(2)(ii) GP following a provisional refusal
June 15, 2021 2021/24 Gaz BR Rejection
May 24, 2021 2021/22 Gaz CH Rejection
March 4, 2021 2021/10 Gaz NO Rejection
March 2, 2021 2021/9 Gaz NZ Rejection
February 8, 2021 2021/7 Gaz IN Rejection
February 1, 2021 2021/5 Gaz IL Rejection
January 11, 2021 2021/3 Gaz IN Rejection
December 26, 2020 2020/53 Gaz SG Rejection
November 10, 2020 2020/47 Gaz RU Rejection
November 3, 2020 2020/47 Gaz CN Rejection
August 11, 2020 2020/34 Gaz IN Rejection
May 14, 2020 2020/26 Gaz US Registration

ID: 141539817